2018 Oncology Annual Report

CANCER REGISTRY DATA – 2017 ANALYTIC CASES * (continued)

PRIMARY SITE

TOTAL

MALE

FEMALE

FEMALE GENITAL SYSTEM

38 21 20 4

0 0 0 0 0 0 0

38 21 20 4

Cervix Uteri

Corpus & Uterus, NOS

Corpus Uteri Uterus, NOS

1 7 6

1 7 6 0 0 0 0 6 4 2 8 5 9 3 4 4 4 1 3 0 0 6 6 0

Ovary Vulva

MALE GENITAL SYSTEM

75 73

75 73

Prostate Testis

1 1

1 1

Other Male Genital Organs

URINARY SYSTEM

26 20 29 14 22 18 34 6 4 32 24 2

20 16 16 4

Urinary Bladder Kidney & Renal Pelvis

BRAIN & OTHER NERVOUS SYSTEM

13

Brain

6

Cranial Nerves, Other Nervous System 15

10

ENDOCRINE SYSTEM

6 3 3

16 15 12 1

Thyroid

Other Endocrine including Thymus

LYMPHOMA

22 20 15 2

Hodgkin Lymphoma Non-Hodgkin Lymphoma

12

NHL - Nodal NHL - Extranodal

8 8 8 7 2 5 1 1

5 4 4 3 1 2 1 1

MYELOMA

Myeloma

LEUKEMIA

Lymphocytic Leukemia Myeloid & Monocytic Leukemia

MESOTHELIOMA Mesothelioma MISCELLANEOUS Miscellaneous

20 20

14 14

TOTAL

783

341

442

*Cases for which AtlantiCare provided the initial diagnosis of cancer and/or for which AtlantiCare contributed to the patient’s first course of treatment.

12 AtlantiCare Cancer Care Institute: Annual Report 2018